Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Prostate Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    December 2022
  1. SUN W, Li L, Du Z, Quan Z, et al
    [Corrigendum] Combination of phospholipase Cepsilon knockdown with GANT61 sensitizes castrationresistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  2. PU J, Li T, Liu N, Luo C, et al
    [Corrigendum] PLCepsilon knockdown enhances the radiosensitivity of castrationresistant prostate cancer via the AR/PARP1/DNAPKcs axis.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    November 2022
  3. CHEN J, Xu D, Wang T, Yang Z, et al
    HMGB1 promotes the development of castrationresistant prostate cancer by regulating androgen receptor activation.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    October 2022
  4. YIN B, Liu Z, Wang Y, Wang X, et al
    [Corrigendum] RON and cMet facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    August 2022
  5. MENDEZ-CLEMENTE A, Bravo-Cuellar A, Gonzalez-Ochoa S, Santiago-Mercado M, et al
    Dual STAT3 and IL6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL6/IL6R/STAT3 axis.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    July 2022
  6. LIN J, Chen Z, Li Z, Nong D, et al
    [Corrigendum] Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    May 2022
  7. XU T, Liu Y, Schulga A, Konovalova E, et al
    Epithelial cell adhesion moleculetargeting designed ankyrin repeat proteintoxin fusion Ec1LoPE exhibits potent cytotoxic action in prostate cancer cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  8. CHEN F, Lu Z, Deng J, Han X, et al
    [Corrigendum] SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    February 2022
  9. GU P, Zhang M, Zhu J, He X, et al
    Suppression of CDCA3 inhibits prostate cancer progression via NFkappaB/cyclin D1 signaling inactivation and p21 accumulation.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    January 2022
  10. LIU J, Zhang Y, Li S, Sun F, et al
    Androgen deprivationinduced OPHN1 amplification promotes castrationresistant prostate cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    December 2021
  11. CHEN B, Bai G, Ma X, Tan L, et al
    MicroRNA1955p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  12. ZHAO J, Li Q, Feng B, Wei D, et al
    MicroRNA149 inhibits cancer cell malignant phenotype by regulating Akt1 in C42 CRPC cell line.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    November 2021
  13. SHENG W, Xu W, Ding J, Li L, et al
    Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR9.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    September 2021
  14. DU W, Li D, Xie J, Tang P, et al
    miR3673p downregulates Rab23 expression and inhibits Hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  15. LIN J, Chen Z, Li Z, Nong D, et al
    Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    August 2021
  16. TORRES MJ, Lopez-Moncada F, Herrera D, Indo S, et al
    Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    July 2021
  17. LI JM, Lee S, Zafar R, Shin E, et al
    Sodium bicarbonate transporter NBCe1 regulates proliferation and viability of human prostate cancer cells LNCaP and PC3.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: